Blogs about SNY - Stockpickr! Your Source for Stock Ideas

Blogs about SNY

Blogs	Description	Date Updated
Albany Molecular Research (AMRI): Stock price consolidating in bullish 'pennant'	Filed under: Earnings reports, Bristol-Myers Squibb (BMY), Technical Analysis, Stocks to BuyAlbany Molecular Research (NASDAQ: AMRI) provides contract services to pharmaceutical and biotechnology companies. The firm offers drug discovery, screening programs, libraries for screening and hit-to-lead programs, and analytical quantification of drugs and metabolites in biological samples. The company also conducts its own research, aiming to license its compounds to other firms for further developmen...	August 12, 2008
Albany Molecular Research (AMRI): Share price cycles in bullish 'flag' formation	Filed under: Earnings reports, Technical Analysis, Stocks to BuyAlbany Molecular Research (NASDAQ: AMRI) provides contract services to pharmaceutical and biotechnology companies. The firm offers drug discovery, screening programs, libraries for screening and hit-to-lead programs, and analytical quantification of drugs and metabolites in biological samples. The company also conducts its own research, aiming to license its compounds to other firms for further development. Albany Molecular owns a p...	June 06, 2008
Sanofi-Aventis (SNY) plunges on Plavix threat in Europe	Filed under: Bad news, Products and services, Launches, Consumer experience, Competitive strategy, Bristol-Myers Squibb (BMY)Shares of French drug maker Sanofi-Aventis (NYSE: SNY) have been tumbling more than 5% in morning trading on news that a Swiss drug maker said it expects to receive approval to sell a generic version of Sanofi's anti-clotting agent Plavix.History is repeating itself. After facing generic competition in the United States to its second-biggest product in 2006, Sanofi-Aventis...	May 09, 2008
Pharmaceutical Stocks and their Patent Expiration Drugs	The next two to four years are an important time frame for many pharmaceutical companies. It is when many of the top selling drugs go off patent. Here is a list of the large pharmas with some of their top selling drugs that are set to 'expire'.AstraZeneca plc (AZN) has the cholesterol drug Crestor, which is set to go off patent in the year 2012. This was recently ranked the 42nd best selling drug. They also have the asthma drug, Symbicort, expires the same year. Their Seroquel, an antipsychotic ...	April 06, 2008
Asthma Stocks	Did you know that during the 1930's and 1940's, asthma was considered a psychosomatic disease? It is now one of the fastest increasing medical conditions in the United States, which reportedly affects one out of every four urban children, according to the Journal of Allergy Clinical Immunology. If you didn't see James Altucher's video interview about George Soros which discusses asthma stocks, you should take a look at it. Here are ten companies involved in the production and marketing of drugs ...	March 31, 2008
Market highlights for next week: Jabil, Oracle to report earnings	Filed under: Pfizer (PFE), Tiffany and Co (TIF), Oracle Corp (ORCL)Monday, March 24 Walgreen Company (NYSE: WAG) to report Q2 earnings; conference call at 8:30am. Tiffany & Co (NYSE: TIF) to report Q2 earnings; conference call at 8:30am. Glu Mobile Inc. (NASDAQ: GLUU) to hold a conference call at 5:00pm to discuss the acquisition of Superscape VR PLC (PINK: SCPDF). Tuesday, March 25 Jabil Circuit, Inc. (NYSE: JBL) to report Q2 earnings; conference call at 4:30pm...	March 20, 2008
Hostility Towards the Bear View	I have been blogging since late summer 2006. Since then, I've spoken my mind, shared my thoughts and beliefs, and tried to clearly discriminate between facts and opinions. And I've presented much of both. I have, as long-time readers know, pretty blunt views on Fed policy, investors' behaviors and the motives of market actors. I feel like I was pretty on top of the pending train wreck, having written about both complacent volatility markets and the likely severity of the subprime fallout. I even...	March 15, 2008
Hostility Towards the Bear View	I have been blogging since late summer 2006. Since then, I've spoken my mind, shared my thoughts and beliefs, and tried to clearly discriminate between facts and opinions. And I've presented much of both. I have, as long-time readers know, pretty blunt views on Fed policy, investors' behaviors and the motives of market actors. I feel like I was pretty on top of the pending train wreck, having written about both complacent volatility markets and the likely severity of the subprime fallout. I even...	March 15, 2008
52 Week Low's 2/11	(UBS)- UBS Ag(UAM )- Universal American Fi ... (TVHU )- Media & Entmt Holding ... (TOD )- Todd Shipyards Corpor ... (SNY )- Sanofi Aventis (SLRY)- Salary Com Inc (SLE )- Sara Lee Corporation (SDXC )- Switch & Data Facilit ... (RDY )- Dr. Reddy's Labs, Ltd.(MENT)- Mentor Graphics Corpo ...(MEND )- Micrus Endovascular Corp (LPNT )- Lifepoint Hospitals Inc (LDIS )- Leadis Technology Inc(HSTX )- Harris Stratex Ntwrks Inc(HMG )- HMG/Courtland Propert ...(HBC )- HSBC Hldgs Plc(GTN )- Gr...	February 11, 2008
52 Week Low's 2/8	(WMK)- Weis Markets, Inc(VSAT )- ViaSat Inc(VRTX )- Vertex Pharmaceutical ...(VNBC )- Vineyard Natl Bancorp(SNY )- Sanofi Aventis(SNCI )- Sonic Innovations Inc(SHMR )- Shamir Optical Indust ...(SCSS )- Select Comfort Corp(RVSN )- Radvision Ltd(RTEC )- Rudolph Technologies Inc(PATR)- Patriot Transn Hldg Inc(OZM )- Och Ziff Cap Mgmt Group(ORIT )- Oritani Finl Corp(OFSI )- Omni Finl Svcs Inc(OESX )- Orion Energy Systems Inc(NT )- Nortel Networks Corp New(NSANY)- Nissan Motors(CTAS )- Cintas ...	February 08, 2008

Enter search text here: